CN1279612A - 免疫应答的调制 - Google Patents

免疫应答的调制 Download PDF

Info

Publication number
CN1279612A
CN1279612A CN98810397A CN98810397A CN1279612A CN 1279612 A CN1279612 A CN 1279612A CN 98810397 A CN98810397 A CN 98810397A CN 98810397 A CN98810397 A CN 98810397A CN 1279612 A CN1279612 A CN 1279612A
Authority
CN
China
Prior art keywords
chemical compound
animal
disease
alkyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98810397A
Other languages
English (en)
Chinese (zh)
Inventor
C·J·兰多尔
G·J·杜普瑞兹
V·R·施拉克
D·C·阿特费尔德
J·B·范丹伯加尔丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FRANGOLD HOLDINGS LTS
Original Assignee
FRANGOLD HOLDINGS LTS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FRANGOLD HOLDINGS LTS filed Critical FRANGOLD HOLDINGS LTS
Publication of CN1279612A publication Critical patent/CN1279612A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN98810397A 1997-09-16 1998-09-16 免疫应答的调制 Pending CN1279612A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA978319 1997-09-16
ZA97/8319 1997-09-16

Publications (1)

Publication Number Publication Date
CN1279612A true CN1279612A (zh) 2001-01-10

Family

ID=25586589

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98810397A Pending CN1279612A (zh) 1997-09-16 1998-09-16 免疫应答的调制

Country Status (10)

Country Link
EP (1) EP1019063A4 (xx)
JP (1) JP2001516721A (xx)
CN (1) CN1279612A (xx)
AU (1) AU737867B2 (xx)
BR (1) BR9812321A (xx)
CA (1) CA2304119A1 (xx)
IL (1) IL135091A0 (xx)
NO (1) NO20001341L (xx)
NZ (1) NZ503418A (xx)
WO (1) WO1999013885A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324631A1 (en) * 2000-10-26 2002-04-26 Virodene Pharmaceutical Holdings (Proprietary) Limited A substance or composition for the treatment of cancer
EP1699430A1 (en) * 2003-12-05 2006-09-13 Namibia Medical Investments (PTY) Limited Patch

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition

Also Published As

Publication number Publication date
AU737867B2 (en) 2001-09-06
AU9389098A (en) 1999-04-05
EP1019063A4 (en) 2003-09-03
IL135091A0 (en) 2001-05-20
WO1999013885A1 (en) 1999-03-25
CA2304119A1 (en) 1999-03-25
JP2001516721A (ja) 2001-10-02
NZ503418A (en) 2001-02-23
EP1019063A1 (en) 2000-07-19
NO20001341L (no) 2000-05-16
NO20001341D0 (no) 2000-03-15
BR9812321A (pt) 2000-09-05

Similar Documents

Publication Publication Date Title
CA2078221C (en) Pharmaceutical compositions comprising taurolidine and/or taurultam
Pratt Response of childhood rhabdomyosarcoma to combination chemotherapy
EP0196415A2 (en) Trichostatins A and C as antitumour drugs
JPS62240619A (ja) 制癌剤
Tawil et al. Acetazolamide‐induced nephrolithiasis: implications for treatment of neuromuscular disorders
KR20020019914A (ko) 암치료용 ｅｔ743의 조성물 및 용도
DE69620233T2 (de) Oxidiertes glutathion als mittel zur verbesserung der endogenen produktion von cytokinen und haematopoietischen faktoren
CN105492426B (zh) N‑(4‑羟基‑4‑甲基‑环己基)‑4‑苯基‑苯磺酰胺和n‑(4‑羟基‑4‑甲基‑环己基)‑4‑(2‑吡啶基)苯磺酰胺和其治疗性用途
Westenfelder et al. Vancomycin-streptomycin synergism in enterococcal endocarditis
RU2073522C1 (ru) Лекарственный препарат противовирусного действия
ES2383005T3 (es) Medicamentos para enfermedades glomerulares
CN1279612A (zh) 免疫应答的调制
WO2004060360A1 (de) Verwendung von wirksubstanzen zur prophylaxe und/oder therapie von viruserkrankungen
PL185678B1 (pl) Nowe zastosowanie dimeru lizozymu
RU2054288C1 (ru) Способ профилактики и лечения острых желудочно-кишечных болезней новорожденных телят
KR20040060958A (ko) 인터페론-γ 생산 촉진제
US3433875A (en) The improvement of mental performance with potassium n-acetyl dl aminosuccinate
RU2703723C1 (ru) Способ коррекции тревожно-депрессивных расстройств у больных с системными заболеваниями соединительной ткани
CN1034133A (zh) 聚集在皮肤内的外用抗病毒药及其制备方法
RU2196576C1 (ru) Способ лечения больных геморрагической лихорадкой с почечным синдромом (глпс)
JPH04202126A (ja) インターロイキン―１産生抑制剤
CN101084892A (zh) 一种抗呼吸道病毒的药物及用途
RU2026072C1 (ru) Средство для стимуляции репаративных процессов
RU2166314C2 (ru) Лечебно-профилактическое средство "гексикон", обладающее антибактериальным и антисептическим действием
Kusum et al. A REVIEW ON SUSTAINED RELEASE TABLETS

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1031837

Country of ref document: HK